GTCR and Corza Health Merge Surgical Specialties and TachoSil to Create Corza Medical
February 1, 2021
GTCR, together with management partner Gregory T. Lucier (Corza Health), acquired Surgical Specialties Corporation and the TachoSil fibrin sealant patch product line from Takeda and merged them to form Corza Medical. The new company, headquartered in Westwood, Massachusetts, operates in 13 countries with manufacturing in the U.S., Mexico, England, Germany and China and a global team of over 1,700 employees.
- Buyers
- GTCR, Corza Health (management partnership led by Gregory T. Lucier)
- Targets
- Surgical Specialties Corporation, TachoSil (fibrin sealant patch product line)
- Sellers
- Takeda Pharmaceutical Company Limited, Vivo Capital and an investor syndicate, ZQ Capital
- Platforms
- Corza Medical
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Corza Medical (GTCR Portfolio Company) Acquires Katena Products from Audax Private Equity
December 2, 2021
Medical Devices
Corza Medical, a GTCR portfolio company, has acquired Katena Products from Audax Private Equity. Katena is a Parsippany, New Jersey–based manufacturer of precision ophthalmic instruments, single-use devices and specialty biologics with more than 200 employees and sales in over 110 countries. Audax, which acquired Katena in 2015, supported the company's operational and M&A-driven growth during its ownership.
-
Corza Medical (GTCR Portfolio) Acquires Barron Precision Instruments
June 8, 2022
Medical Devices
GTCR-backed Corza Medical has acquired Barron Precision Instruments (BPI), a founder-owned manufacturer of disposable ophthalmic surgery devices based in Grand Blanc, Michigan. The add-on expands Corza's ophthalmology portfolio and manufacturing footprint, supporting its Corza Ophthalmology business unit and GTCR's continued buildout of the platform.
-
Solventum Completes Acquisition of Acera Surgical
December 23, 2025
Healthcare Services
Solventum completed its acquisition of Acera Surgical, a privately held bioscience company focused on regenerative wound care. The deal includes $725 million in upfront cash plus up to $125 million in contingent cash payments tied to future milestones.
-
GTCR Affiliate Acquires Surmodics, Inc.
November 10, 2025
Medical Devices
Surmodics announced that a U.S. district court denied the FTC and certain state regulators’ request for a preliminary injunction to block the company’s proposed acquisition by an affiliate of GTCR. Surmodics said the merger remains subject to a temporary restraining order and customary closing conditions, with the company expecting to move toward closing promptly.
-
GTCR Invests in Biocoat
November 2, 2022
Medical Devices
GTCR has made a strategic, majority recapitalization investment in Biocoat Holdings, LLC, a Horsham, Pennsylvania-based provider of biocompatible hydrophilic coatings and dip-coating equipment for medical devices. Existing investor 1315 Capital and Biocoat management retain minority stakes; GTCR will partner with CEO Jim Moran and add industry veteran Chip Hance as Executive Chairman to support growth, capability expansion and follow-on acquisitions.
-
BioVentrix Acquires MateraCor, Inc.
January 27, 2022
Medical Devices
BioVentrix, a privately held medical device company focused on less invasive left-ventricle therapies, has acquired MateraCor, Inc., a Southern California start-up developing an injectable alginate-based hydrogel and delivery system (TCMR) to prevent and reverse heart failure. The deal expands BioVentrix’s product portfolio for left ventricular restoration and adds development expertise as the company builds a platform of complementary heart-failure therapies.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.